# Daye

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/daye

- Industry: Consumer Products
- Headquarters: London, UK
- Website: www.yourdaye.com
- Total disclosed funding: $15M
- Latest round: Series A (Aug 19, 2022)
- Investors on record: 7

## About

Based in the UK, Daye is a company focused on developing sustainable and health-centric menstrual products that address women's needs during their cycles while promoting environmental responsibility.Daye, founded in 2018 and headquartered in London, UK, specializes in innovative menstrual care solutions. The founder, Valentina, previously led other initiatives in women's health. The company has completed three funding deals, most recently raising GBP 8.45 million in a Series A round on August 19, 2022, with investors including Cross-Border Impact Ventures and Gaingels. The total amount raised is GBP 8.45 million with a current company valuation of GBP 36.293 million.Daye specializes in providing sustainable and innovative period products that prioritize both women's health and environmental responsibility. Their core offerings include organic and CBD-infused tampons, super absorbent hemp blend pads, and a unique diagnostic tampon for at-home screening of HPV and other health conditions. These products are designed to address various issues women face during their menstrual cycles, such as period pain, heavy bleeding, and the need for reliable sexual health screening. Daye's products cater primarily to women seeking eco-friendly and health-conscious alternatives to traditional menstrual care items, marketed to consumers in the UK and select international markets.Daye generates revenue through direct-to-consumer sales via their online platform, where customers can purchase individual products or bundles tailored to their specific needs. The pricing strategy includes a personal tampon box at GBP 9.48 and a vaginal health bundle priced at GBP 115, indicating a tiered approach to product offerings. Additionally, Daye offers subscription options, allowing customers to receive regular deliveries of their preferred products, enhancing customer retention and ensuring consistent revenue flow. The company also engages in partnerships with healthcare providers to facilitate screenings and diagnoses, further expanding its revenue channels tied to health services and consumer goods.Daye plans to utilize the GBP 8.45 million raised in Series A funding to support product expansion across the US market. This includes the development and launch of new products aimed at addressing women's health needs, with further details on specific product releases to be announced. The company is strategically targeting the US for market expansion, aligning with its goal to reach more women in regions that value sustainable health solutions.

## Funding rounds

- Series A, Aug 19, 2022, $10M — MassMutual Ventures, Salica Investments, Gaingels, Cross-Border Impact Ventures
- Seed, Apr 30, 2019, $3.8M — Index Ventures, Khosla Ventures, Kindred Capital
- Seed, Sep 7, 2018, $1.7M — Index Ventures, Kindred Capital

## Investors

- Index Ventures (https://capitalatlas.ai/funds/index-ventures) — Seed
- Kindred Capital (https://capitalatlas.ai/funds/kindred-capital) — Seed
- Khosla Ventures (https://capitalatlas.ai/funds/khosla-ventures) — Seed
- MassMutual Ventures (https://capitalatlas.ai/funds/massmutual-ventures) — Series A
- Salica Investments (https://capitalatlas.ai/funds/salica-investments) — Series A
- Gaingels (https://capitalatlas.ai/funds/gaingels) — Series A
- Cross-Border Impact Ventures (https://capitalatlas.ai/funds/cross-border-impact-ventures) — Series A